ConductScience.org, home

Paper25829397

Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy.

Mok T and 19 others. Clin Cancer Res, 2015. Cited by 416 papers, by iCite.

Cite this record

ConductScience Library. Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy. Papers, record 25829397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25829397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy.
PubMed
Journal
Clin Cancer Res
PubMed
Year
2015
PubMed
Publication types
Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
416
iCite
Relative citation ratio, by iCite
12.5
iCite
Revised in PubMed
2026-08-26
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mok TTony
2Wu YLYi-Long
3Lee JSJin Soo
4Yu CJChong-Jen
5Sriuranpong VVirote
6Sandoval-Tan JJennifer
7Ladrera GGuia
8Thongprasert SSumitra
9Srimuninnimit VVichien
10Liao MMeilin
11Zhu YYunzhong
12Zhou CCaicun
13Fuerte FFatima
14Margono BBenjamin
15Wen WWei
16Tsai JJulie
17Truman MMatt
18Klughammer BBarbara
19Shames DSDavid S
20Wu LLin

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Carcinoma, Non-Small-Cell LungMajor topic
DNA Mutational AnalysisMajor topic
DNA, NeoplasmMajor topic
Lung NeoplasmsMajor topic
Aged
Deoxycytidine
Disease-Free Survival
Double-Blind Method
Erlotinib Hydrochloride
Female
Genes, erbB-1
Humans
Intercalating Agents
Kaplan-Meier Estimate
Male
Middle Aged
Mutation
Platinum Compounds
Treatment Outcome
Gemcitabine

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT03090815Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung AdenocarcinomaBackgroundClinicalTrials.gov
NCT04358562Gefitinib With Anlotinib in Advanced Non-squamous NSCLC Patients With Uncleared Plasma ctDNA EGFRm After First-line Treatment With GefitinibResultsClinicalTrials.gov

Download CSV of trials

Cited by269

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 416 citations.

PMIDTitleJournalYearIn PapersSource
42098393Liquid Biopsy in Primary CNS Tumors: Bridging Biology, Technology, and Clinical Care.Mol Diagn Ther2026https://conductscience.org/library/papers/42098393PubMed
41890329Bibliometric Analysis of Randomized Clinical Trials in the Philippines.Acta Med Philipp2026https://conductscience.org/library/papers/41890329PubMed
41677996The progress of biomarkers detection to lung cancer.Discov Oncol2026https://conductscience.org/library/papers/41677996PubMed
41519536Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact.J Thorac Oncol2026https://conductscience.org/library/papers/41519536PubMed
40830279Oncogene-driven lung cancer in the era of radiogenomics: current evidence and future developments.Discov Oncol2025https://conductscience.org/library/papers/40830279PubMed
40825939The prognostic role of circulating DNA markers in patients with lung malignancies: a systematic review and meta-analysis.Biomark Med2025https://conductscience.org/library/papers/40825939PubMed
40776748Comprehensive genetic profiling using tissue and blood in locally advanced tumors.Oncol Rep2025https://conductscience.org/library/papers/40776748PubMed
40465842Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP Study.Clin Cancer Res2025https://conductscience.org/library/papers/40465842PubMed
40299851Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer.Cancer Discov2025https://conductscience.org/library/papers/40299851PubMed
40219616Liquid Biopsy in Solid Tumours: An Overview.Cytopathology2025https://conductscience.org/library/papers/40219616PubMed
40144458The prospects and limitations of liquid biopsy utilization for clinical practice in Taiwan.J Liq Biopsy2025https://conductscience.org/library/papers/40144458PubMed
40065316Efficacy of liquid biopsy for genetic mutations determination in non-small cell lung cancer: a systematic review on literatures.BMC Cancer2025https://conductscience.org/library/papers/40065316PubMed
39844103Multiple time points for detecting circulating tumor DNA to monitor the response to neoadjuvant therapy in breast cancer: a meta-analysis.BMC Cancer2025https://conductscience.org/library/papers/39844103PubMed
39830755Can circulating tumor DNA guide treatment de-escalation in metastatic lung adenocarcinoma harboring actionable genomic alterations?Transl Lung Cancer Res2024https://conductscience.org/library/papers/39830755PubMed
39769431The Role of ctDNA in the Management of Non-Small-Cell Lung Cancer in the AI and NGS Era.Int J Mol Sci2024https://conductscience.org/library/papers/39769431PubMed
39353410A Comprehensive Review of Epidermal Growth Factor Receptor Mutation Abundance in Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors.Oncol Res Treat2024https://conductscience.org/library/papers/39353410PubMed
39317868Analysis of genomic alternations in epidermal growth factor receptor (EGFR)-T790M-mutated non-small cell lung cancer (NSCLC) patients with acquired resistance to osimertinib therapy.Clin Transl Oncol2025https://conductscience.org/library/papers/39317868PubMed
39239557Clinical applications of circulating biomarkers in non-small cell lung cancer.Front Cell Dev Biol2024https://conductscience.org/library/papers/39239557PubMed
39231375Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer.JCO Precis Oncol2024https://conductscience.org/library/papers/39231375PubMed
39184861Mechanisms of resistance to tyrosine kinase inhibitor-targeted therapy and overcoming strategies.MedComm (2020)2024https://conductscience.org/library/papers/39184861PubMed

See all 269 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956

Source NCBI Gene

Download CSV of genes

Drugs2

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
CATEQUENTINIBCHEMBL4303201Results1https://conductscience.org/library/drugs/CHEMBL4303201ChEMBL
GEFITINIBCHEMBL939Results1https://conductscience.org/library/drugs/CHEMBL939ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25829397

GET https://conductscience.org/api/papers/v1/25829397/cited_by?page=2